Kytril 1mg film-coated tablets Ireland - English - HPRA (Health Products Regulatory Authority)

kytril 1mg film-coated tablets

atnahs pharma netherlands b.v. - granisetron hydrochloride - film-coated tablet - 1 milligram(s) - serotonin (5ht3) antagonists; granisetron

Kytril 2mg film-coated tablets Ireland - English - HPRA (Health Products Regulatory Authority)

kytril 2mg film-coated tablets

atnahs pharma netherlands b.v. - granisetron hydrochloride - film-coated tablet - 2 milligram(s) - serotonin (5ht3) antagonists; granisetron

Kytril 3 mg/3 ml solution for injection Ireland - English - HPRA (Health Products Regulatory Authority)

kytril 3 mg/3 ml solution for injection

atnahs pharma netherlands b.v. - granisetron hydrochloride - solution for injection - 3 milligram(s)/millilitre - serotonin (5ht3) antagonists; granisetron

KYTRIL granisetron (as hydrochloride) 2mg tablet blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

kytril granisetron (as hydrochloride) 2mg tablet blister pack

atnahs pharma australia pty ltd - granisetron hydrochloride, quantity: 2.24 mg (equivalent: granisetron, qty 2 mg) - tablet, film coated - excipient ingredients: magnesium stearate; microcrystalline cellulose; lactose monohydrate; sodium starch glycollate; hypromellose; titanium dioxide; polysorbate 80; macrogol 400 - adults: kytril (tablets and injection) is indicated for use in adults for: the prevention of nausea and vomiting induced by cytotoxic chemotherapy; the prevention of nausea and vomiting induced by radiotherapy.

Zestril 5mg Tablets Malta - English - Medicines Authority

zestril 5mg tablets

atnahs pharma netherlands b.v. copenhagen towers Ørestads boulevard 108, 5.tv dk-2300 københavn s , denmark - lisinopril dihydrate - tablet - lisinopril dihydrate 5 mg - agents acting on the renin-angiotensin system

Sunosi European Union - English - EMA (European Medicines Agency)

sunosi

atnahs pharma netherlands b.v. - solriamfetol hydrochloride - narcolepsy; sleep apnea, obstructive - psychoanaleptics, - sunosi is indicated to improve wakefulness and reduce excessive daytime sleepiness in adult patients with narcolepsy (with or without cataplexy).sunosi is indicated to improve wakefulness and reduce excessive daytime sleepiness (eds) in adult patients with obstructive sleep apnoea (osa) whose eds has not been satisfactorily treated by primary osa therapy, such as continuous positive airway pressure (cpap). 

Zestril 10 mg Tablets Ireland - English - HPRA (Health Products Regulatory Authority)

zestril 10 mg tablets

atnahs pharma netherlands b.v. - lisinopril - tablet - 10 milligram(s) - ace inhibitors, plain; lisinopril

Zestril 20mg Tablets Ireland - English - HPRA (Health Products Regulatory Authority)

zestril 20mg tablets

atnahs pharma netherlands b.v. - lisinopril - tablet - 20 milligram(s) - ace inhibitors, plain; lisinopril

Zestril 5mg Tablets Ireland - English - HPRA (Health Products Regulatory Authority)

zestril 5mg tablets

atnahs pharma netherlands b.v. - lisinopril - tablet - 5 milligram(s) - ace inhibitors, plain; lisinopril

Zestril 10mg Tablets Malta - English - Medicines Authority

zestril 10mg tablets

atnahs pharma netherlands b.v. copenhagen towers Ørestads boulevard 108, 5.tv dk-2300 københavn s , denmark - lisinopril dihydrate - tablet - lisinopril dihydrate 10 mg - agents acting on the renin-angiotensin system